MASKED
Initial Public Health Case Report - Zika Example
Relevant diagnostic tests/laboratory data Narrative
Reportability Response Information Section
Reportability response report Document Public health
Extracorporeal membrane oxygenator (physical object)
Swallow - dosing instruction imperative (qualifier value)
1 ML naloxone hydrochloride 0.4 MG/ML Injection
Inject - dosing instruction imperative (qualifier value)
Blood pressure panel with all children optional
Ethnicity / related nationality data (observable entity)
United Kingdom of Great Britain and Northern Ireland
Are you deaf, or do you have serious difficulty hearing
Nursing, psychiatric, and home health aides
Gestational age Estimated from patient reported estimated date of conception
Delivery date Estimated from date fundal height reaches umb
Lymphocytes [#/volume] in Blood by Automated count
Fort Mojave Indian Tribe of Arizona, California & Nevada
Extracorporeal membrane oxygenation (procedure)
Zika virus envelope E gene [Presence] in Serum by NAA with probe detection
Description of rule used in reportability determination
Health Authority West Responsible Agency
Health Authority West Rules Authoring Agency
Additional information for the required reporting of Zika must be submitted to State Department of Health immediately. This additional information can be submitted here.
Zika has particular risks for pregnant women. Follow-up guidance for pregnant women and couples who are planning pregnancy.
Local mosquito-borne Zika virus creation was reported in your area. Increased watchfulness for symptoms of Zika virus in your patients is warranted.